세계의 안과용 디바이스 시장 규모는 2022년에 283억 3,000만 달러로 평가되며, 2023년 295억 2,000만 달러에서 2031년에는 362억 6,000만 달러에 달하며, 예측 기간(2024-2031년) CAGR로 4.2%의 성장이 예상되고 있습니다.
안과용 진단 디바이스 시장은 광간섭단층촬영(OCT), 안저영상진단과 같은 영상진단 기술의 발전으로 안질환의 민감도와 조기 발견이 향상됨에 따라 큰 성장이 예상되고 있습니다. 이러한 기술 발전과 더불어 미세절개 백내장 수술(MICS), 레이저 보조 굴절술과 같은 최소침습적 수술 기법에 대한 관심이 높아지고 있으며, 정확성과 안전성이 향상되고 회복 시간이 단축되면서 시장 수요를 더욱 촉진하고 있습니다. 또한 특히 신흥 경제권에서 의료비 지출이 증가함에 따라 첨단 안과 기술 및 시술의 도입이 촉진되고 있지만, 시장 출시 시간 및 규정 준수 비용과 관련된 문제가 여전히 남아 있습니다.할 것으로 예상되는 세계 인구의 고령화로 인한 인구 통계학적 변화도 시장 성장을 가속하는 매우 중요한 요인입니다. 특히 아프리카와 라틴아메리카 등의 지역에서 노인 인구가 빠르게 증가하고 있는 것은 심혈관 질환을 포함한 다양한 질병의 발병 위험이 증가하고 있는 것과 관련이 있습니다. 의료 시스템은 고령화 사회의 요구에 부응하기 위해 첨단 진단 및 치료법을 제공하는 데 점점 더 중점을 두고 있으며, 이러한 인구 통계학적 추세는 안과용 디바이스 분야에서 큰 시장 기회를 창출하고 있습니다. 이러한 기술 혁신, 수술의 발전, 인구 통계학적 변화가 결합되어 안과용 진단 기기 분야의 성장에 대한 강력한 전망을 제시하고 있습니다.
Global Ophthalmology Devices Market size was valued at USD 28.33 Billion in 2022 and is poised to grow from USD 29.52 Billion in 2023 to USD 36.26 Billion by 2031, growing at a CAGR of 4.2% in the forecast period (2024-2031).
The ophthalmic diagnostic devices market is poised for significant growth driven by ongoing advancements in imaging technologies like Optical Coherence Tomography (OCT) and fundus imaging, enhancing the sensitivity and early detection of ocular diseases. This technological progress is coupled with the rising trend toward minimally invasive surgical techniques, such as microincision cataract surgery (MICS) and laser-assisted refraction procedures, known for their improved accuracy, safety, and quicker recovery times, which further fuels market demand. Additionally, growing healthcare expenditures, particularly in emerging economies, are facilitating the adoption of sophisticated ophthalmic technologies and procedures, although challenges related to time to market and compliance costs remain. The demographic shift towards an aging global population, projected to reach 771 million individuals aged 65 and older by 2022, with numbers expected to escalate to 1.6 billion by 2050, is another pivotal factor driving market growth. The rapid increase of elderly individuals, particularly in regions such as Africa and Latin America, correlates with a heightened risk of developing various diseases, including cardiovascular ailments. This demographic trend underscores a significant market opportunity within the ophthalmic devices sector, as healthcare systems increasingly focus on providing advanced diagnostics and treatments to address the needs of an aging population. Thus, the combination of technological innovations, surgical advancements, and demographic shifts suggests a robust landscape for growth in the ophthalmic diagnostic devices sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the global ophthalmology devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
global ophthalmology devices Market Segmental Analysis
Based on the product, the ophthalmology devices market is segmented into surgical & vision care. By application the ophthalmology devices market is segmented into cataract and glaucoma. Based on the end-user, the global market is segmented into hospitals, ophthalmic clinics, eye clinics and others. Geographically, the global ophthalmology devices market has been segmented into Asia-Pacific, North America, Europe, and the Middle East & Africa, and Latin America.
Driver of the global ophthalmology devices Market
The rising incidence of eye infections and related discomfort is a significant driver for the global ophthalmology devices market. With an increase in pollution levels and the prevalence of irritants-such as smoke, dust, and harsh cosmetics-the demand for reliable diagnostic and therapeutic ophthalmology devices is surging. Conditions like blepharitis and dry eyes further exacerbate the need for effective interventions. Moreover, growing awareness of ocular health and continuous advancements in the pharmaceutical sector enhance the urgency for innovative ophthalmic devices, thereby increasing market growth. As eye health becomes a priority for consumers and healthcare providers alike, the market is poised for expansion.
Restraints in the global ophthalmology devices Market
The global ophthalmology devices market faces significant restraints due to several factors prevalent in emerging countries. A decrease in per capita healthcare expenditure hampers the ability to invest in advanced ophthalmic treatments and technologies. Additionally, limited product accessibility restricts the distribution and adoption of innovative devices, further impeding patient care. Compounding these challenges is a lack of awareness regarding ophthalmic diseases, leading to a lower number of patients seeking necessary treatments. For instance, disparities in surgical rates, such as the cataract surgery procedures observed in China compared to the U.S., illustrate the existing limitations that hinder market growth in these regions.
Market Trends of the global ophthalmology devices Market
The global ophthalmology devices market is experiencing robust growth, driven by the increasing demand for innovative equipment, accessories, and contact lenses among healthcare professionals and patients. Notably, advancements such as micro-invasive glaucoma surgeries (MIGs) have emerged as a rapidly growing segment, catering to the treatment needs for mild to moderate glaucoma. Furthermore, market players are directing their efforts toward developing advanced micro-invasive cataract surgical implants, which are expected to enhance surgical outcomes and patient satisfaction. This trend highlights a shift toward less invasive procedures, ultimately propelling the expansion of the ophthalmic devices market in the coming years.